The global industry for Active Pharmaceutical Ingredient (API) manufacturers is a complex landscape, encompassing numerous areas . The People’s Republic of China currently holds the output of APIs, second to India, which is a significant player in both non-branded API provision . European firms , particularly in countries like Germany, Switzerlan